/
•
•
Detailed stories on technology startups, business and economic current affairs.

The opportunity beckons. For the global pharmaceutical industry, it’s a race against the clock to vaccinate the world’s population against COVID-19. And, who better than India to supply the shots, in the cheapest and quickest way possible.
The only Indian company that has made headlines so far is the Pune-based Serum Institute of India, which also happens to be the world’s largest manufacturer of vaccines. The company tied up with AstraZeneca, to bring a vaccine developed by the British-Swedish multinational firm along with UK’s Oxford University to the Indian market. SII will produce a billion doses of the vaccine by …